The purpose of this experiment was to evaluate whether modified CAV2-AU-M2 retained the same infection efficiency, conditional replication, and oncolytic activity in canine osteosarcoma (OS) cell lines as its precursor, ICOCAV15. Here, CAV2 is linked to infection.